Who
Sean C. Flynn
Chief Legal Officer
Company insider
Files Form 4 as: Chief Legal Officer, Vericel.
In numbers
- Trades disclosed
- 129
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $7.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2020
- Last trade
- 26 Jun 2026
- Last filed
- 30 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $685K15,000 at $45.64 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 26 Jun 2026filed 30 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $685K15,000 at $45.64 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $603K15,000 at $40.21 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 18 Jun 2026filed 22 Jun 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $603K15,000 at $40.21 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $223K6,421 at $34.75 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $530K15,000 at $35.36 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL Vericeloption or derivative · Biotechnology | SEC FORM 4 Code M | —15,000 at $0.00 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $223K6,421 at $34.75 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Code M | $244K15,000 at $16.25 | filing |
| 2 Mar 2026filed 4 Mar 2026 | VCEL VericelBiotechnology | SEC FORM 4 Sold | $530K15,000 at $35.36 | filing |
News
No headline names them, or the companies they trade most, lately.